Managing Team
Stefano Iacobelli, MD – Co-Founder and Chief Executive Officer
Dr. Stefano Iacobelli was Professor of Medical Oncology at the University “G. D’Annunzio” of Chieti-Pescara, Italy and Coordinator of the PhD program in Molecular Pathology and Oncology. Dr. Iacobelli has more than 30 years of experience in the translational and clinical oncology. He served as Full Professor of Medical Oncology, Head of Cancer Clinic and Coordinator, PhD Program in Molecular and Clinical Oncology at the University “G. D’Annunzio”. He was founder and Director of the National Consortium for Cancer Research (CINBO), a network of 18 Universities focusing on translational research on oncology and founder and President of Mediterranean Task Force for Cancer Control (MTCC). Dr. Iacobelli was cofounder at U3 Pharma, a German biotechnology company focusing on research into small molecules and antibodies for the treatment of cancer, later sold to Daiichi-Sankyo Co, Ltd. Dr. Iacobelli main research interests include tumor growth control mechanisms and pre-clinical and clinical development of anti-cancer drugs. Presently, Dr. Iacobelli is focusing on the discovery and development of monoclonal antibodies and antibody-drug conjugates. He is author of over 250 publications in international peer reviewed journals and co-inventor in 15 patents
Responsabile Ricerca Anticorpi
Jean-Frederic Sauniere, MD, PhD – CoFounder, VP Business Development & Chief Operating Officer
Dr. Jean-Frederic Sauniere, medical oncologist, obtained his MD and PhD from the University of Medicine, Marseille, France. Dr. Sauniere brings 25 years of experience in translational, clinical research and drug development. He served as Director of Clinical Research, then Director of Corporate Licensing & Business development at Pfizer, New York and as Vice-President of Anaderm, a subsidiary of Pfizer. Dr. Sauniere was an executive in several early stage pharmaceutical companies in the US and CEO of Shogoo Pharmaceuticals in Basel, Switzerland.
Pier Giorgio Natali, MD, PhD – Co-Founder, Chief Scientific Officer, Immunology & Precision Medicine
Dr. Natali was Professor of Medicine and Oncology. He graduated from “La Sapienza” University of Rome, Italy, and trained in Experimental Immuno-pathology in the USA and has focused his scientific career in basic and translational oncology. As President of the Italian Cancer Society and Scientific Director of the “Regina Elena”, a leading nationwide comprehensive cancer center in Italy, he has contributed to many areas of the fight against cancer including prevention, early diagnosis, education and advocacy. He has served in strategic international boards and Co-Founded the Chart of Paris. Dr. Natali has published over 350 studies with high citation record. He is presently Fellow of the Collegium Ramazzini and served in the Advisory Board of Cancer Today Magazine, edited by the AACR. He is also the Secretary General of Mediterranean Task Force for Cancer Control (MTCC). He has published over 350 studies with high Citation Index.
Specializzata in tecniche all’avanguardia per l’analisi e ottimizzazione dei candidati terapeutici.